The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Apr. 07, 2020
Filed:
Mar. 31, 2016
Applicant:
Laboratoire Francais Du Fractionnement ET Des Biotechnologies, Les Ulis, FR;
Inventors:
Nathalie Fournier, Erquinghem-Lys, FR;
Alexandre Fontayne, La Madeleine, FR;
Christophe de Romeuf, Lambersart, FR;
Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 16/00 (2006.01); C07K 16/46 (2006.01); C07K 16/28 (2006.01); C07H 21/04 (2006.01); C12P 21/06 (2006.01); C12N 15/87 (2006.01); C12N 1/20 (2006.01); C12N 15/74 (2006.01); C12N 15/79 (2006.01);
U.S. Cl.
CPC ...
C07K 16/2851 (2013.01); C12N 15/79 (2013.01); C07K 2317/14 (2013.01); C07K 2317/24 (2013.01); C07K 2317/52 (2013.01); C07K 2317/54 (2013.01); C07K 2317/55 (2013.01); C07K 2317/56 (2013.01); C07K 2317/565 (2013.01); C07K 2317/567 (2013.01); C07K 2317/622 (2013.01); C07K 2317/732 (2013.01); C07K 2317/734 (2013.01); C07K 2317/76 (2013.01); C07K 2317/77 (2013.01); C07K 2317/92 (2013.01); C12N 2510/00 (2013.01);
Abstract
The invention relates to chimeric or humanised anti-CD303 antibodies to nucleic acids coding for the heavy and light chains of these antibodies, expression vectors, host cells, transgenic non-human animals or transgenic plants expressing said antibodies, as well as to the uses thereof in the treatment or prevention of blastic plasmacytoid dendritic cell neoplasms (BPDCN) or inflammatory diseases, in particular autoimmune diseases, involving plasmacytoid dendritic cells.